You are here

Our science / Clinical Trials / Find a Trial / NCT00541476

Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica

Back to Search Print Save as PDF Bookmark Trial

NCT00541476

Last updated on May 11, 2018
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Neuralgia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18+ years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Clinical diagnosis of peripheral or central neuropathic pain

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- None. Patients recruited by physician decision. Patient's personal data are not
collected.

NCT00541476
Pfizer
Completed
Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Advanced Search

Similar Trials

Postherpetic Neuralgia
A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia
NCT00394901
All Genders
18+
Years
Multiple Sites
Diabetic Neuropathies, Neuralgia
Pregabalin Peripheral Neuropathic Pain Study
NCT00141219
All Genders
18+
Years
Multiple Sites
Postherpetic Neuralgia ( PHN )
Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)
NCT01455428
All Genders
18+
Years
Multiple Sites
Postherpetic Neuralgia
A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia
NCT00424372
All Genders
18+
Years
Multiple Sites
Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica
Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Undergoing Symptomatic Treatment With Lyrica
The purpose of this study is to obtain more data about efficacy and safety of the study drug Lyrica.
Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Neuralgia
Not Provided
Not Provided
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
746
December 2007
December 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of peripheral or central neuropathic pain

Exclusion Criteria:

  • None. Patients recruited by physician decision. Patient's personal data are not collected.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00541476
A0081178
Not Provided
Not Provided
Not Provided
Director, Clinical Trials Disclosure Group, Pfizer, Inc
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
November 2008

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now